Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	534.39	390.4	292.73
Revenue Growth (YoY)	82.55%	33.37%	-
Cost of Revenue	113.17	89.81	98.55
Gross Profit	421.22	300.59	194.18
Selling, General & Admin	611.81	227.54	214.64
Research & Development	354.4	97.49	110.06
Operating Expenses	967.14	325.02	324.69
Operating Income	-545.93	-24.43	-130.51
Interest & Investment Income	19.1	20.57	21.7
Other Non Operating Income (Expenses)	0.3	0.08	0.27
EBT Excluding Unusual Items	-526.53	-3.78	-108.55
Merger & Restructuring Charges	-6.79	-7.48	-
Pretax Income	-533.32	-11.26	-108.55
Income Tax Expense	-0.08	0.68	-0.41
Net Income	-533.24	-11.93	-108.14
Net Income to Common	-429.07	-11.93	-108.14
Shares Outstanding (Basic)	38	14	13
Shares Outstanding (Diluted)	38	14	13
Shares Change (YoY)	192.34%	4.16%	-
EPS (Basic)	-11.28	-0.88	-8.31
EPS (Diluted)	-11.28	-0.88	-8.31
Free Cash Flow	145.43	47.96	-65.89
Free Cash Flow Per Share	3.82	3.54	-5.06
Gross Margin	78.82%	77.00%	66.33%
Operating Margin	-102.16%	-6.26%	-44.59%
Profit Margin	-80.29%	-3.06%	-36.94%
Free Cash Flow Margin	27.21%	12.29%	-22.51%
EBITDA	-543.75	-22.08	-128.39
EBITDA Margin	-101.75%	-5.66%	-43.86%
D&A For EBITDA	2.18	2.35	2.13
EBIT	-545.93	-24.43	-130.51
EBIT Margin	-102.16%	-6.26%	-44.59%
Advertising Expenses	-	37.3	23.8

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q